image
Evolus, Inc. EOLS
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 12.11
1.94 %
$ 767 M
Market Cap
-13.31
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 35.98% 17.10% 14.49%
Annual Report FY 10-K 2022-12-31 49.10% -58.97% 9.49%
Annual Report FY 10-K 2021-12-31 76.29% 71.28% 7.40%
Annual Report FY 10-K 2020-12-31 61.89% -81.06% 27.52%
Annual Report FY 10-K 2019-12-31 0.00% -92.11% -105.42%
Annual Report FY 10-K 2018-12-31 0.00% -946.14% -293.50%
Annual Report FY 10-K 2017-12-31 0.00% 77.67% 41.27%
Annual Report FY 10-K 2016-12-31 0.00% 35.51% 35.55%
Annual Report FY 10-K 2015-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 23.85% -13.28% -15.13%
Quarterly Report Q2 8-K 2024-06-30 35.59% 37.43% 59.67%
Quarterly Report Q1 8-K 2024-03-31 42.21% 11.37% 29.33%
Quarterly Report Q4 8-K 2023-12-31 39.76% 10.13% 42.43%
Quarterly Report Q3 8-K 2023-09-30 45.50% 16.54% 19.43%
Quarterly Report Q2 8-K 2023-06-30 32.78% 22.71% 29.18%
Quarterly Report Q1 8-K 2023-03-31 23.04% 15.48% 26.46%
Quarterly Report Q4 8-K 2022-12-31 25.94% 27.58% 51.06%
Quarterly Report Q3 8-K 2022-09-30 27.07% -4.34% 12.77%
Quarterly Report Q2 8-K 2022-06-30 42.40% -50.45% -39.51%
Quarterly Report Q1 8-K 2022-03-31 177.00% -273.41% -176.34%
Quarterly Report Q4 8-K 2021-12-31 68.43% 83.58% 83.30%
Quarterly Report Q3 8-K 2021-09-30 51.05% -69.59% -118.29%
Quarterly Report Q2 8-K 2021-06-30 234.33% 26.15% 18.98%
Quarterly Report Q1 8-K 2021-03-31 16.63% 132.43% 146.07%
Quarterly Report Q4 8-K 2020-12-31 5.81% -662.99% -761.25%
Quarterly Report Q3 8-K 2020-09-30 34.13% 57.53% 65.15%
Quarterly Report Q2 8-K 2020-06-30 237.78% 43.77% 47.53%
Quarterly Report Q1 8-K 2020-03-31 0.00% -79.82% 31.16%
Quarterly Report Q4 8-K 2019-12-31 0.00% -16.61% -0.28%
Quarterly Report Q3 8-K 2019-09-30 0.00% -128.10% -118.80%
Quarterly Report Q2 8-K 2019-06-30 0.00% -128.61% -123.58%
Quarterly Report Q1 8-K 2019-03-31 0.00% -78.11% -318.01%
Quarterly Report Q4 8-K 2018-12-31 0.00% -279.72% -337.65%
Quarterly Report Q3 8-K 2018-09-30 0.00% -349.13% -339.18%
Quarterly Report Q2 8-K 2018-06-30 0.00% -615.72% -607.69%
Quarterly Report Q1 8-K 2018-03-31 0.00% -54.13% -52.00%
Quarterly Report Q4 8-K 2017-12-31 0.00% 218.84% 22.86%
Quarterly Report Q3 8-K 2017-09-30 0.00% 36.68% 37.04%
Quarterly Report Q2 8-K 2017-06-30 0.00% 62.24% 62.42%
Quarterly Report Q1 8-K 2017-03-31 0.00% 34.25% 34.30%
Quarterly Report Q4 8-K 2016-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2016-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2016-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2016-03-31 0.00% 0.00% 0.00%